134 related articles for article (PubMed ID: 15893843)
1. VEGF-induced angiogenesis drives collateral circulation in portal hypertension.
Moreau R
J Hepatol; 2005 Jul; 43(1):6-8. PubMed ID: 15893843
[No Abstract] [Full Text] [Related]
2. Inhibition of VEGF receptor-2 decreases the development of hyperdynamic splanchnic circulation and portal-systemic collateral vessels in portal hypertensive rats.
Fernandez M; Mejias M; Angermayr B; Garcia-Pagan JC; Rodés J; Bosch J
J Hepatol; 2005 Jul; 43(1):98-103. PubMed ID: 15893841
[TBL] [Abstract][Full Text] [Related]
3. Hemodynamic changes in splanchnic blood vessels in portal hypertension.
Colle I; Geerts AM; Van Steenkiste C; Van Vlierberghe H
Anat Rec (Hoboken); 2008 Jun; 291(6):699-713. PubMed ID: 18484617
[TBL] [Abstract][Full Text] [Related]
4. Increased angiogenesis and permeability in the mesenteric microvasculature of rats with cirrhosis and portal hypertension: an in vivo study.
Geerts AM; De Vriese AS; Vanheule E; Van Vlierberghe H; Mortier S; Cheung KJ; Demetter P; Lameire N; De Vos M; Colle I
Liver Int; 2006 Sep; 26(7):889-98. PubMed ID: 16911473
[TBL] [Abstract][Full Text] [Related]
5. Anti-VEGF receptor-2 monoclonal antibody prevents portal-systemic collateral vessel formation in portal hypertensive mice.
Fernandez M; Vizzutti F; Garcia-Pagan JC; Rodes J; Bosch J
Gastroenterology; 2004 Mar; 126(3):886-94. PubMed ID: 14988842
[TBL] [Abstract][Full Text] [Related]
6. [Portal hypertension and angiogenesis].
Stumm M; Sieber C
Schweiz Med Wochenschr; 2000 Feb; 130(7):233-9. PubMed ID: 10719714
[TBL] [Abstract][Full Text] [Related]
7. Vascular deterioration in cirrhosis: the big picture.
Bosch J
J Clin Gastroenterol; 2007; 41 Suppl 3():S247-53. PubMed ID: 17975472
[TBL] [Abstract][Full Text] [Related]
8. Angiogenesis in portal hypertension: involvement in increased splanchnic blood flow and collaterals?
Geerts AM; Colle I
Acta Clin Belg; 2007; 62(5):271-5. PubMed ID: 18229459
[No Abstract] [Full Text] [Related]
9. Portal-systemic collaterals and angiogenesis.
Chan CC
J Chin Med Assoc; 2009 May; 72(5):223-4. PubMed ID: 19467943
[No Abstract] [Full Text] [Related]
10. Nitric oxide and portal hypertension: interface of vasoreactivity and angiogenesis.
Langer DA; Shah VH
J Hepatol; 2006 Jan; 44(1):209-16. PubMed ID: 16297493
[No Abstract] [Full Text] [Related]
11. Molecular mechanisms of increased intrahepatic resistance in portal hypertension.
Shah V
J Clin Gastroenterol; 2007; 41 Suppl 3():S259-61. PubMed ID: 17975474
[TBL] [Abstract][Full Text] [Related]
12. Mild increases in portal pressure upregulate vascular endothelial growth factor and endothelial nitric oxide synthase in the intestinal microcirculatory bed, leading to a hyperdynamic state.
Abraldes JG; Iwakiri Y; Loureiro-Silva M; Haq O; Sessa WC; Groszmann RJ
Am J Physiol Gastrointest Liver Physiol; 2006 May; 290(5):G980-7. PubMed ID: 16603731
[TBL] [Abstract][Full Text] [Related]
13. Different vascular endothelial growth factor (VEGF), VEGF-receptor 1 and -2 mRNA expression profiles between clear cell and papillary renal cell carcinoma.
Ljungberg BJ; Jacobsen J; Rudolfsson SH; Lindh G; Grankvist K; Rasmuson T
BJU Int; 2006 Sep; 98(3):661-7. PubMed ID: 16925769
[TBL] [Abstract][Full Text] [Related]
14. Pro-angiogenic cytokines and their role in tumor angiogenesis.
Neufeld G; Kessler O
Cancer Metastasis Rev; 2006 Sep; 25(3):373-85. PubMed ID: 17006765
[TBL] [Abstract][Full Text] [Related]
15. Portal hypertension and variceal hemorrhage.
Toubia N; Sanyal AJ
Med Clin North Am; 2008 May; 92(3):551-74, viii. PubMed ID: 18387376
[TBL] [Abstract][Full Text] [Related]
16. Portal hypertension and blood viscosity.
Sikuler E
J Clin Gastroenterol; 2007; 41 Suppl 3():S262-5. PubMed ID: 17975475
[TBL] [Abstract][Full Text] [Related]
17. [A new view on angiogenesis and effect of dearterialization of the liver in the surgery of portal hypertension and oncohepatology].
Kashchenko VA
Vestn Khir Im I I Grek; 2003; 162(2):114-6. PubMed ID: 14606165
[No Abstract] [Full Text] [Related]
18. [Systemic hemodynamics and blood coagulation in portal hypertension. Pathophysiologic and therapeutic aspects].
Kühn HA; Liehr H
Med Klin; 1977 Oct; 72(42):1713-20. PubMed ID: 335205
[No Abstract] [Full Text] [Related]
19. Lymphangiogenesis and angiogenesis in conventional renal cell carcinoma: association with vascular endothelial growth factors A to D immunohistochemistry.
Iwata T; Miyata Y; Kanda S; Nishikido M; Hayashi T; Sakai H; Kanetake H
Urology; 2008 Apr; 71(4):749-54. PubMed ID: 18295862
[TBL] [Abstract][Full Text] [Related]
20. Vascular endothelial growth factor family of ligands and receptors: review.
Otrock ZK; Makarem JA; Shamseddine AI
Blood Cells Mol Dis; 2007; 38(3):258-68. PubMed ID: 17344076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
